|
|
- 2019
Common Questions and Misconceptions in the Management of Renal Transplant Patients: A Guide for Health Care Providers in the Posttransplant SettingKeywords: renal transplant,drug interactions,drug safety,urinary tract infection,herpes zoster,angiotensin converting enzyme inhibitors,angiotensin II receptor blockers,fluoroquinolones,immunosuppressant medications,HMG-CoA reductase inhibitors,sodium-glucose cotransporter 2 inhibitors,skin malignancy,immunizations,antidepressants Abstract: Once renal transplant recipients are stabilized and require less frequent follow-up with their transplant team, health care providers outside of the transplant setting play an integral role in patients’ ongoing medical care. Given renal transplant recipients’ inherent complexity, these health care providers often seek consult regarding decisions that may affect transplant-related medications or outcomes. In this review, we discuss answers to 10 of the questions commonly posed to our renal transplant team by other health care providers
|
